Study shows an increased risk of breast cancer recurrence in postmenopausal patients with obesity and HR+ early-stage breast cancer treated with aromatase inhibitors.
The new study found an 80% increase in cancer among people under 50 over the last three decades. Screening and prevention programs for early-onset cancer may be worth exploring.